Acquiring UK-based Clinical Force will give Medidata its first significant clinical trial management system (CTMS). The CTMS is offered on a software-as-a-service (SaaS) basis and this is one of a number of characteristics that Medidata feels make it a good fit for its eClinical portfolio.
“Clinical Force CTMS is a SaaS solution that is very low risk and easily scalable”, Graham Bunn, vice president of partnerships and alliances at Medidata, told Outsourcing-Pharma at DIA. Being scalable makes the system a viable option for clinical trials using just a handful of sites, right up to global studies spanning continents.
The deal is due to close by the end of September but Medidata has already begun looking at integration. Smoothing the interface with other products in the Medidata range and aligning the look of the CTMS with the rest of the suite are priorities.